Zactran is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 8 US drug patents filed from 2016 to 2018. All patents have expired. Details of Zactran’s patents and their expiration are given below.
Exclusivity Information
Zactran holds 2 exclusivitys out of which 2 have expired. Details of Zactran's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Feb 08, 2015 |
| NCE | Jun 16, 2016 |
About Zactran
Zactran is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Zactran uses
Gamithromycin as the active
ingredient.
Active Ingredient:
Zactran uses
Gamithromycin as the active ingredient.
Check out other Drugs and Companies using
Gamithromycin ingredient.